Novo Rise Logo - Search News

Novo Nordisk Skeptic Finally Upgrades Stock

Novo Nordisk Skeptic Finally Upgrades Stock After Drop From Peak

A long-term Novo Nordisk A/S skeptic recommended buying shares of the Danish weight-loss drug maker nine years after starting coverage of the stock.

Markets Insider · 3d

Why This Long-Time Skeptic Finally Upgraded Novo Nordisk (NVO) to Buy

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after

Seeking Alpha on MSN · 3d

Novo Nordisk rebounds as Kepler upgrades Ozempic maker at long last

Novo Nordisk (NVO) ended a five-day losing streak on Thursday after Kepler Cheuvreux, a long-time skeptic of the Danish biotech, finally issued a bullish rating on the maker of hugely popular obesity/ diabetes drugs,

Yahoo Finance19d

Novo shares rise as HIMS halt sales of some obesity drugs

Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in ...

Hosted on MSN2mon

A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%

The logo of Danish pharmaceutical company Novo Nordisk is pictured at their headquarters ... saw their stocks rise 5% and 3%, respectively, on Friday.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Novo Nordisk Skeptic Finally Upgrades Stock

Trending now